Y. Tsunenari

发表

Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors

T. Sakaeda, H. Fujino, T. Saito, 2004, Xenobiotica; the fate of foreign compounds in biological systems.

Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase (1) : Absorption, Distribution, Metabolism and Excretion in Rats

H. Fujino, Y. Tsunenari, H. Kimata, 1998 .

INTERACTION BETWEEN FIBRATES AND STATINS - METABOLIC INTERACTIONS WITH GEMFIBROZIL

M. Hirano, H. Fujino, Y. Tsunenari, 2003, Drug metabolism and drug interactions.

Interaction between Several Medicines and Statins

H. Fujino, Y. Tsunenari, J. Kojima, 2003, Arzneimittelforschung.

Design, synthesis and pharmacology of aortic-selective acyl-CoA: Cholesterol O-acyltransferase (ACAT/SOAT) inhibitors.

Y. Tsunenari, Y. Yoshinaka, K. Shibuya, 2018, Bioorganic & medicinal chemistry.

Effect of Gemfibrozil on the Metabolism of Pitavastatin - Determining the Best Animal Model for Human CYP And UGT Activities

H. Fujino, Y. Tsunenari, J. Kojima, 2004, Drug metabolism and drug interactions.

Pharmacokinetics and metabolism of pemafibrate, a novel selective peroxisome proliferator‐activated receptor‐alpha modulator, in rats and monkeys

H. Yamazaki, Y. Tsunenari, H. Kawai, 2019, Biopharmaceutics & drug disposition.

Discovery of Clinical Candidate 2-(4-(2-((1 H-Benzo[ d]imidazol-2-yl)thio)ethyl)piperazin-1-yl)- N-(6-methyl-2,4-bis(methylthio)pyridin-3-yl)acetamide Hydrochloride [K-604], an Aqueous-Soluble Acyl-CoA:Cholesterol O-Acyltransferase-1 Inhibitor.

Y. Tsunenari, Y. Yoshinaka, K. Shibuya, 2018, Journal of medicinal chemistry.

Brain Targeting of Acyl-CoA:Cholesterol O-Acyltransferase-1 Inhibitor K-604 via the Intranasal Route Using a Hydroxycarboxylic Acid Solution

Y. Urano, Y. Tsunenari, N. Noguchi, 2019, ACS omega.

Prediction of circulating human metabolites of pemafibrate, a novel antidyslipidemic drug, using chimeric mice with humanized liver

H. Yamazaki, H. Suemizu, Y. Tsunenari, 2019, Xenobiotica; the fate of foreign compounds in biological systems.

Studies on the Interaction between Fibrates and Statins Using Human Hepatic Microsomes

M. Hirano, H. Fujino, Y. Tsunenari, 2003, Arzneimittelforschung.